US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q2 2026)
- 28
- Value
- $1.76K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28 | $1.76K | <0.1% | −26−48.1% | Reduced | Holders |
| Q1 2026 | 54 | $3.79K | <0.1% | +36+200.0% | Added | Holders |
| Q4 2025 | 18 | $1.47K | <0.1% | −65−78.3% | Reduced | Holders |
| Q3 2025 | 83 | $4.93K | <0.1% | +8+10.7% | Added | Holders |
| Q2 2025 | 75 | $3.04K | <0.1% | +47+167.9% | Added | Holders |
| Q1 2025 | 28 | $1.44K | <0.1% | +28 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −79−100.0% | Sold out | Holders |
| Q1 2024 | 79 | $2.87K | <0.1% | −36−31.3% | Reduced | Holders |
| Q4 2023 | 115 | $2.33K | <0.1% | +115 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −79−100.0% | Sold out | Holders |
| Q4 2022 | 79 | $1.16K | <0.1% | −57−41.9% | Reduced | Holders |
| Q3 2022 | 136 | $2.00K | <0.1% | +136 | New | Holders |